BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28682883)

  • 1. Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma: Case report.
    Chen YH; Liu FC; Hsu CH; Chian CF
    Medicine (Baltimore); 2017 Jul; 96(27):e7350. PubMed ID: 28682883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review.
    Chen JH; Lee KY; Hu CJ; Chung CC
    Medicine (Baltimore); 2017 Dec; 96(50):e9262. PubMed ID: 29390370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature.
    Veccia A; Kinspergher S; Grego E; Peterlana D; Berti A; Tranquillini E; Caffo O
    Anticancer Drugs; 2020 Jun; 31(5):540-544. PubMed ID: 32011360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of anti-titin antibody positive nivolumab-related necrotizing myopathy with myasthenia gravis].
    Isami A; Uchiyama A; Shimaoka Y; Suzuki S; Kawachi I; Fujita N
    Rinsho Shinkeigaku; 2019 Jul; 59(7):431-435. PubMed ID: 31243249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of myasthenia gravis and myositis induced by nivolumab].
    Konoeda F; Suzuki S; Nishimoto Y; Hoshino H; Takagi M
    Rinsho Shinkeigaku; 2017 Jul; 57(7):373-377. PubMed ID: 28674287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
    Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
    J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder.
    Chang E; Sabichi AL; Sada YH
    J Immunother; 2017 Apr; 40(3):114-116. PubMed ID: 28234667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.
    Kang KH; Grubb W; Sawlani K; Gibson MK; Hoimes CJ; Rogers LR; Lavertu P; Yao M
    Am J Otolaryngol; 2018; 39(5):642-645. PubMed ID: 29903623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis and myopathy after nivolumab treatment for non-small cell lung carcinoma: A case report.
    Kim JS; Nam TS; Kim J; Kho BG; Park CK; Oh IJ; Kim YC
    Thorac Cancer; 2019 Oct; 10(10):2045-2049. PubMed ID: 31436031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsed Myasthenia Gravis after Nivolumab Treatment.
    Mitsune A; Yanagisawa S; Fukuhara T; Miyauchi E; Morita M; Ono M; Tojo Y; Ichinose M
    Intern Med; 2018 Jul; 57(13):1893-1897. PubMed ID: 29434145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.
    Hasegawa Y; Kawai S; Ota T; Tsukuda H; Fukuoka M
    Immunotherapy; 2017 Aug; 9(9):701-707. PubMed ID: 28649876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma.
    Shirai T; Sano T; Kamijo F; Saito N; Miyake T; Kodaira M; Katoh N; Nishie K; Okuyama R; Uhara H
    Jpn J Clin Oncol; 2016 Jan; 46(1):86-8. PubMed ID: 26491202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsy case of nivolumab-induced myasthenia gravis and myositis].
    Sawai T; Hosokawa T; Shigekiyo T; Ogawa S; Sano E; Arawaka S
    Rinsho Shinkeigaku; 2019 Jun; 59(6):360-364. PubMed ID: 31142711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: A case report of successful management.
    Yanase T; Moritoki Y; Kondo H; Ueyama D; Akita H; Yasui T
    Urol Case Rep; 2021 Jan; 34():101508. PubMed ID: 33318935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of myasthenia gravis and myositis induced by pembrolizumab].
    Noda T; Kageyama H; Miura M; Tamura T; Ito H
    Rinsho Shinkeigaku; 2019 Aug; 59(8):502-508. PubMed ID: 31341124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis induced by inmuno checkpoints inhibitors: first case report secondary to avelumab therapy and review of published cases].
    Reyes-Bueno JA; Rodriguez-Santos L; Serrano-Castro PJ
    Rev Neurol; 2019 Apr; 68(8):333-338. PubMed ID: 30963530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis induced by nivolumab therapy in a patient with non-small-cell lung cancer.
    Polat P; Donofrio PD
    Muscle Nerve; 2016 Sep; 54(3):507. PubMed ID: 27121245
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report].
    Miyashita K; Kajikawa H; Utsunomiya T; Hosaka M; Naito Y; Tomimoto H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):768-772. PubMed ID: 33115992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma.
    Kishi S; Minato M; Saijo A; Murakami N; Tamaki M; Matsuura M; Murakami T; Nagai K; Abe H; Nishioka Y; Doi T
    Intern Med; 2018 May; 57(9):1259-1263. PubMed ID: 29279511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.